NTLA INTELLIA THERAPEUTICS INC
2026Q1 · CUSIP 45826J105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
302
Δ holders QoQ
+9
Breadth percentile
Top 31%
Whale holders
147
Δ whales
+9
Inst. holding value
$1.4B
New positions
63
Closed positions
54
Price momentum (1Q)
+3.8%
Put / Call
6/12
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2022Q3 | Top 5% | -20.1% | -16.9% |
| 2021Q3 | Top 5% | -30.3% | -65.9% |
| 2021Q2 | Top 1% | -13.4% | -40.8% |
| 2020Q4 | Top 7% | -2.1% | +124.0% |
| 2020Q2 | Top 15% | +59.4% | +230.0% |
| 2018Q2 | Top 7% | -39.2% | -51.1% |
| 2018Q1 | Top 11% | +7.8% | -34.5% |
Options Sentiment
Put holders
6
QoQ: -3
Call holders
12
QoQ: -5
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-3.52
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+45.0%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)